Verséa Diagnostics is a division of Verséa Holdings, Inc. bringing point of care diagnostic solutions to healthcare providers and patients. Our model of partnerships and licensing high utility diagnostic tests provides us with the flexibility to adapt to existing and future global diagnostic needs in the market. Our current focus is on infection management and control in the large practice, ambulatory surgical and institutional clinic setting.
Verséa has strategic partnerships providing access to Bulk Drug Tests, COVID-19 Tests and Molecular Tests to hospitals, private practices, and Ambulatory Surgery Centers (ASC’s) across the United States. The Verséa team of experts continues to research and identify the highest quality tests that are made to the highest standards. All the testing offered is FDA Approved or Emergency Use Authorized (EUA). Verséa provides personalized customer service. You deal with one Company (Verséa) and have direct access to the latest testing.
With rights to distribution and ongoing studies at investigational sites across the USA, Verséa is providing education, marketing, and distribution of the tests in the US and globally. To receive more information about the COVID-19 Antibody Testing Kit, click here.